These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 11096182)

  • 1. Antiplatelet agents in stroke prevention. combination therapy: present and future.
    Weksler BB
    Cerebrovasc Dis; 2000; 10 Suppl 5():41-8. PubMed ID: 11096182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimizing antiplatelet therapy in coronary interventions.
    King SB
    Clin Cardiol; 2000 Nov; 23 Suppl 6(Suppl 6):VI-8-13. PubMed ID: 11129685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New antiplatelet agents.
    White HD; French JK; Ellis CJ
    Aust N Z J Med; 1998 Aug; 28(4):558-64. PubMed ID: 9777140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet therapy for ischemic heart disease.
    Lange RA; Hillis LD
    N Engl J Med; 2004 Jan; 350(3):277-80. PubMed ID: 14724308
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of antiplatelet drugs in the prevention of cardiovascular events.
    Tendera M; Wojakowski W
    Thromb Res; 2003 Jun; 110(5-6):355-9. PubMed ID: 14592562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases.
    Bhatt DL; Kapadia SR; Yadav JS; Topol EJ
    Cerebrovasc Dis; 2000; 10 Suppl 5():34-40. PubMed ID: 11096181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet therapy in coronary artery disease: review and update of efficacy studies.
    Tisdale JE
    Am J Health Syst Pharm; 1998 Oct; 55(19 Suppl 1):S8-16. PubMed ID: 9784797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New antiaggregants and their importance for the practitioner].
    Tsakiris DA
    Ther Umsch; 2003 Jan; 60(1):24-6. PubMed ID: 12638474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet agents for stroke prevention.
    Paciaroni M; Gallai V
    Cerebrovasc Dis; 2000; 10 Suppl 4():36-9. PubMed ID: 11070399
    [No Abstract]   [Full Text] [Related]  

  • 10. Newer antiplatelet therapies in stroke prevention.
    Davis SM; Donnan GA
    Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
    Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
    Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New antiplatelet agents].
    Diez-Ewald
    Invest Clin; 2000 Sep; 41(3):147-8. PubMed ID: 11029831
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
    Tran H; Anand SS
    JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapy.
    Boden WE; Hoekstra J; Miller CD
    Am J Emerg Med; 2008 Feb; 26(2):212-20. PubMed ID: 18272105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin in patients with coronary artery disease: is it simply irresistible?
    Nair GV; Davis CJ; McKenzie ME; Lowry DR; Serebruany VL
    J Thromb Thrombolysis; 2001 Apr; 11(2):117-26. PubMed ID: 11406726
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence with antiplatelet therapy and ADP-receptor antagonists.
    Easton JD
    Cerebrovasc Dis; 2003; 16 Suppl 1():20-6. PubMed ID: 12698015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.
    Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL
    JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet agents.
    Varon D; Spectre G
    Hematology Am Soc Hematol Educ Program; 2009; ():267-72. PubMed ID: 20008209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet medications and their indications in preventing and treating coronary thrombosis.
    Van De Graaff E; Steinhubl SR
    Ann Med; 2000 Nov; 32(8):561-71. PubMed ID: 11127934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.